Dr. Flora Momen-Heravi, recipient of multiple Irving Institute for Clinical and Translational Research pilot grants, has been awarded a U01 and an R35 grants.
The winning projects focus on research or inventions that are on a path to commercialization and have real-world applications in the clinic that can impact patient care and diagnosis.
Many women 75 and older may not need routine mammograms, the decision to screen should be based on life expectancy, overall health, and personal preferences.
Study finds a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.